Four-year EuroQol initiative to help accelerate COVID-19 related research ends

Over the duration of the COVID-19 pandemic emergency, the EuroQol Research Foundation offered study-specific licenses free of charge to commercial customers wishing to use EQ-5D instruments in studies aimed at testing COVID-19 treatments or diagnostic tools. During this period, numerous commercial organisations undertook COVID-19 related research around the world using EQ-5D instruments – with EuroQol forgoing license fees equivalent to more than € 1 million. 

Now that a year has passed since the World Health Organisation determined that the COVID-19 pandemic no longer constitutes a public health emergency of international concern, the EuroQol Board has decided that the time is right to end our COVID-19 research support initiative. From the 1^st December 2024, licensing of EQ-5D instruments for use in the COVID-19 related studies will be aligned with EuroQol’s standard licensing policy